Core Laboratories N.V. (CLB)

ENERGY: ENERGY EQUIPMENT & SERVICES
SIC: OIL & GAS FIELD SERVICES, NEC

STRAWINSKYLAAN 913 1077 XX AMSTERDAM, NETHERLANDS 1077 XX

Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world.

Data as of 2021-09-19 11:39:15 -0400
Market Cap1.274 Billion Shares Outstanding46.331 Million Avg 30-day Volume449.288 Thousand
P/E Ratio39.00527 Dividend Yield0.145 EPS0.718
Price/Sales2.86 Debt to Equity3.99 EBITDA75.822 Million
Price to Book Value8.49 Forward PE1.31 Enterprise Value1.449 Billion
Total Cash33.617 Million Current Debt90.854 Million Gross Profit99.312 Million
BETA1.45547 52-week High/Low49.85 / 13.42 Next Earnings Date2021-10-27 Price to Cash FLow (P/CF) 139.0728
Data provided by IEX Cloud
View SEC Filings from CLB instead.

View recent insider trading info

Core Laboratories N.V. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CLB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CLB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TATTOLI MARK DAMIAN SVP, GEN COUNSEL & SECRETARY

  • Officer
 5,075 2021-07-02 1

DANIELS KEVIN CAO & TREASURER

  • Officer
 3,026 2021-07-01 5

SCHREFFLER GWENDOLYN SVP

  • Officer
 4,933 2021-06-18 3

TEMENG KWAKU

  • Director
 4,307 2021-05-19 2

VAN KEMPEN MARGARET ANN

  • Director
 12,823 2021-04-01 1

STRAUGHEN MICHAEL

  • Director
 15,488 2021-04-01 1

CARNES MARTHA Z.

  • Director
 25,107 2021-04-01 1

BARNETT GREGORY BARRY

  • Director
 33,907 2021-04-01 1

KLINGENSMITH HARVEY ROBERT

  • Director
 20,741 2021-04-01 1

VAN DIJKEN EEUWIJK MONIQUE

  • Director
 11,633 2021-04-01 1

ELVIG MARK F SVP, GEN COUNSEL & SECRETARY

  • Officer
 6,900 2021-02-19 2

HILL CHRISTOPHER SCOTT SVP & CFO

  • Officer
 33,950 2021-02-19 2

BRUNO LAWRENCE CHAIRMAN AND CEO

  • Officer
  • Director
 94,172 2021-02-19 2

SODDERLAND JAN WILLEM

  • Director
 7,852 2020-05-07 0

GOLDMAN SACHS GROUP INC

GOLDMAN SACHS & CO. LLC

4,640,900 2020-04-01 0

DEMSHUR DAVID M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 0 2020-02-11 0

DUNLAP CHARLES L

  • Director
 8,062 2019-04-01 0

VAN GEUNS LUCIA

  • Director
 3,596 2019-04-01 0

BERGMARK RICHARD L EVP & CFO

  • Officer
  • Director
 0 2018-02-13 0

DAVIS MONTY L CHIEF OPERATING OFFICER

  • Officer
 0 2018-02-13 0

KEARNEY MICHAEL C

  • Director
 13,798 2017-03-31 0

OGREN D JOHN

  • Director
 41,506 2016-03-31 0

MILLER CHARLES BRIGHAM CAO & TREASURER

  • Officer
 42,384 2014-12-31 0

PERNA JOSEPH R

  • Director
 0 2013-05-01 0

JOYCE RENE R

  • Director
 11,823 2013-02-04 0

VRIESENDORP ALEXANDER

  • Director
 0 2012-04-01 0

SCHOUTEN JACOBUS

  • Director
 0 2011-04-01 0

DENSON JOHN D VP, COUNSEL & SECRETARY

  • Officer
 127,614 2008-02-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CORE LABORATORIES N.V. CLB 2021-09-21 22:15:03 UTC -0.1811 0.2511 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 21:45:03 UTC -0.1808 0.2508 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 21:15:03 UTC -0.1808 0.2508 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 20:45:03 UTC -0.18 0.25 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 20:15:03 UTC -0.18 0.25 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 19:45:03 UTC -0.18 0.25 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 19:15:03 UTC -0.18 0.25 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 18:45:03 UTC -0.18 0.25 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 18:15:03 UTC -0.18 0.25 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 17:45:03 UTC -0.18 0.25 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 17:15:03 UTC -0.18 0.25 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 16:45:03 UTC -0.18 0.25 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 16:15:03 UTC -0.18 0.25 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 15:45:04 UTC -0.18 0.25 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 15:15:04 UTC -0.18 0.25 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 14:45:03 UTC -0.2889 0.3589 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 14:15:03 UTC -0.2889 0.3589 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 13:45:03 UTC -0.2889 0.3589 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 13:15:03 UTC -0.2889 0.3589 2100000
CORE LABORATORIES N.V. CLB 2021-09-21 12:45:03 UTC -0.2889 0.3589 2100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund CLB -207.0 shares, $-9650.34 2019-09-30 N-PORT

Elevate your investments